Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

619
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
619
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

939
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
939
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

298
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
298
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.2K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

543
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
543
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

653
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
653

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank.

Journal of the American Heart Association·2026
Same author

Cardioprotective therapy in type 2 diabetes guided by a proteomic risk model: A randomized trial.

American journal of preventive cardiology·2026
Same author

Racism-Related Concern for Children and Central Hemodynamics in African American Women: A Longitudinal Study.

Biopsychosocial science and medicine·2026
Same author

Age at type 2 diabetes diagnosis, mortality, and health loss in South Asians.

Diabetes research and clinical practice·2026
Same author

Dyslipidemia and therapies after heart transplantation: Current evidence and future directions.

Journal of clinical lipidology·2026
Same author

The Comparative Prognostic Value of High Sensitivity Troponin Level and Stress Testing in Patients With Stable Coronary Artery Disease.

Journal of the American College of Cardiology·2026

Related Experiment Video

Updated: Feb 18, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.3K

Biomarkers to Predict Cardiovascular Death.

Devinder S Dhindsa1, Jay Khambhati1, Pratik B Sandesara1

  • 1Division of Cardiology, Department of Medicine, Emory University School of Medicine, 1462 Clifton Road Northeast, Suite 507, Atlanta, GA 30322, USA.

Cardiac Electrophysiology Clinics
|November 28, 2017
PubMed
Summary

Biomarkers help identify individuals at high risk for cardiovascular death, especially those with heart disease. A multimarker approach combined with clinical factors improves risk assessment for sudden cardiac death.

Keywords:
BiomarkersCardiovascular deathRisk scoreRisk stratification

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.9K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.8K

Related Experiment Videos

Last Updated: Feb 18, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.3K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.9K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.8K

Area of Science:

  • Cardiovascular Medicine
  • Biomarker Discovery
  • Risk Stratification

Background:

  • Cardiovascular diseases remain a leading cause of mortality worldwide.
  • Accurate identification of individuals at high risk for cardiovascular death is crucial for timely intervention.
  • Biomarkers offer potential for improved risk assessment beyond traditional clinical factors.

Purpose of the Study:

  • To review current biomarkers for identifying individuals at increased risk of cardiovascular death.
  • To evaluate the evolving role of biomarkers in risk stratification for sudden cardiac death.
  • To assess the utility of multimarker strategies in different patient populations.

Main Methods:

  • Systematic review of published literature on cardiovascular biomarkers and risk prediction.
  • Analysis of studies focusing on general population, coronary artery disease (CAD), and heart failure cohorts.
  • Evaluation of multimarker strategies incorporating circulating proteins and clinical risk factors.

Main Results:

  • Biomarkers have demonstrated efficacy in identifying elevated cardiovascular death risk across diverse populations.
  • A multimarker strategy, combining protein measures and clinical factors, shows promise for near-term risk prediction in established CAD.
  • The cost-effectiveness of applying similar multimarker strategies to the general population requires further investigation.

Conclusions:

  • Biomarker-based risk stratification is a valuable tool in cardiovascular medicine.
  • Multimarker approaches, particularly in patients with coronary artery disease, enhance the identification of individuals at high risk for mortality.
  • Further research is needed to determine the clinical and economic benefits of widespread biomarker use for cardiovascular risk assessment in the general population.